Cover Image
市場調查報告書

體外診斷 (IVD):技術及全球市場

In Vitro Diagnostics: Technologies and Global Markets

出版商 BCC Research 商品編碼 345450
出版日期 內容資訊 英文 192 Pages
訂單完成後即時交付
價格
Back to Top
體外診斷 (IVD):技術及全球市場 In Vitro Diagnostics: Technologies and Global Markets
出版日期: 2015年11月23日 內容資訊: 英文 192 Pages
簡介

全球體外診斷 (IVD) 市場2014年為573億美金。預計該市場今後到2020以年複合成長率6.1%擴大,從2015年的603億美元到2020年成為811億美元。

本報告提供全球體外診斷 (IVD) 市場概要及技術趨勢、到2020年的預測、應用領域、終端用戶趨勢、各地區趨勢,以及產業的主要企業簡介彙整。

第1章 簡介

第2章 摘要

第3章 市場情況

  • 市場概要與市場區隔
  • 主要調查結果
  • 全球體外診斷影響市場的因素
    • 促進要素
    • 阻礙要素
  • 法律制度
    • 北美
    • 歐洲
    • 亞洲
    • 南美

第4章 各子分類市場

  • 簡介
  • 種類
    • 免疫化學
    • POC檢驗
    • 分子診斷
    • 血液學
    • 臨床微生物學
    • 組織診斷
  • 市場區隔趨勢
  • 競爭結構

第5章 全球免疫化學市場

第6章 全球POC檢驗市場

第7章 全球血液學市場

第8章 全球分子診斷市場

第9章 全球臨床微生物學市場

第10章 全球組織診斷市場

第11章 各終端用戶市場

  • 簡介
  • 趨勢

第12章 全球體外診斷產品

第13章 各地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 南美
  • 國際醫療費與趨勢

第14章 技術趨勢與發展

  • 趨勢
  • 產業的發展
  • 學術研究開發

第15章 技術開發機會

第16章 資金分析與產業活動

第17章 專利環境

第18章 企業簡介

  • ABBOTT DIAGNOSTICS INC. ?GEOGRAPHIC REACH
  • ALERE SAN DIEGO INC.
  • BAYER DIABETES CARE
  • BECKMAN COULTER
  • BECTON DICKINSON
  • BIORAD
  • ELITECH GROUP
  • HOLOGIC INC.
  • KEM-EN-TEC DIAGNOSTICS A/S
  • ORTHO CLINICAL DIAGNOSTICS
  • ROCHE DIAGNOSTICS CORP.
  • SIEMENS HEALTHCARE DIAGNOSTICS INC.
  • SYSMEX
  • THERMO FISHER SCIENTIFIC INC.
  • TRANSASIA BIO-MEDICALS
  • WERFEN GROUP

第19章 附錄

圖表

目錄
Product Code: HLC186A

REPORT HIGHLIGHTS

The global market for in vitro diagnostics (IVD) products was totaled at $57.3 billion in 2014. It is expected to grow from $60.3 billion in 2015 to $81.1 billion by 2020 at a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

This report provides:

  • An overview of the global markets and related technologies for in vitro diagnostics
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD
  • Information about IVD products including reagents, instruments, and data management softwares and services
  • A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing both in hospitals and laboratories
  • Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis and tissue diagnostics
  • Geographical breakdowns
  • Application analysis: Diabetes, infectious, oncology, cardiology, neurology and others.
  • Profiles of major players in the industry

SCOPE OF REPORT

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines the IVD market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study are diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas:

  • Structure and current market size of the IVD market as outlined with forecasts through 2020.
  • Impact of chronic diseases, growing and aging populations.
  • Current technology and product suppliers and key innovations.
  • A look at the IVD industry and trends affecting the market.
  • Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics) provide a global overview showing market data for the U.S., Europe, Asia and LAAM regions.
  • Emerging opportunities and potential investment opportunity areas for IVD.
  • Technology patent trends relating to IVD.
  • Profiles for more than 20 companies in the industry with significant contributions and market shares.

ANALYST'S CREDENTIALS

Sangeetha Prabakar is an experienced market research analyst with over 13 years of professional experience in research/consulting/competitive intelligence in the life sciences sector with varied coverage in pharmaceuticals, biotechnology, medical devices and imaging, patient monitoring, clinical diagnostics and drug discovery sectors. Ms. Sangeetha has specialized in biochemistry and human genetics in her academic studies. Though her vast experience and in-depth knowledge gained over the years, she provides strategic analysis and recommendations in her market studies, enabling the readers to make informed decisions.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTION OF THE STUDY AND FOR WHOM
  • SCOPE OF REPORT
  • METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • INTRODUCTION
  • GLOBAL MARKET TRENDS
  • SUMMARY TABLE: GLOBAL IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL IVD MARKET BY REGION, 2013-2020 ($ MILLIONS)

CHAPTER 3 - MARKET LANDSCAPE

  • MARKET OVERVIEW AND SEGMENTATION
    • FIGURE 1: MARKET SEGMENTATION
  • KEY FINDINGS
  • FACTORS INFLUENCING THE GLOBAL IVD MARKET
    • DRIVERS
      • Need for Disease Detection before Appearance of Symptoms
      • Need to Identify the Right Patients for Drug Therapy
      • Need for Faster Real-Time Tests that Enable Personalized Treatment
      • Point-of-Care Tests that Minimize Dependency on Lab Testing
      • Improving Healthcare Budgets Drive Demand for IVD in Emerging Markets
      • Rising Aging Population and Global Incidence of Chronic Diseases
      • Discovery of New Biomarkers and Advances in Molecular Techniques
      • Public and Environmental Health Monitoring Requires the Use of IVDs for Faster Diagnosis and Treatment
    • RESTRAINTS
      • Declining Reimbursement for IVDs in Europe Reduces Growth
      • U.S. Medical Device Tax Reduces Profits for Manufacturers
      • Stringent Regulatory Framework to Stifle the Growth of IVD Market
      • High R&D and Marketing Costs
      • Regulatory Disparities and the Expansion of Laboratory-developed Tests
  • REGULATORY LANDSCAPE
    • IVD REGULATIONS IN NORTH AMERICA
      • U.S.
        • TABLE 1: TYPES OF DIAGNOSTIC TESTS AND HOW THEY ARE REGULATED
      • Canada
    • IVD REGULATIONS IN EUROPE
    • IVD REGULATIONS IN ASIA
      • Japan
      • China
      • India
      • Australia and New Zealand
      • Malaysia
      • Singapore
        • TABLE 2: CHANGES IN IVD REGULATIONS IN ASIA
    • IVD REGULATIONS IN LAAM
      • Brazil
      • Mexico
      • Israel
      • Saudi Arabia
      • South Africa

CHAPTER 4 - GLOBAL IVD MARKET BY SUBCATEGORIES

  • INTRODUCTION
  • DESCRIPTION
    • IMMUNOCHEMISTRY
    • POC TESTING
    • MOLECULAR DIAGNOSTICS
    • HEMATOLOGY
    • CLINICAL MICROBIOLOGY
    • TISSUE DIAGNOSTICS
  • TRENDS IN IVD SEGMENTS
    • TABLE 3: GLOBAL IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • FIGURE 2: GLOBAL IVD MARKET BY SEGMENT, 2013-2020 ($ MILLIONS)
    • FIGURE 3: GLOBAL IVD MARKET SHARE BY SEGMENT, 2014 (%)
  • COMPETITIVE STRUCTURE
    • MARKET SHARE ANALYSIS
      • TABLE 4: MAJOR IVD MARKET COMPANIES, 2014 ($ MILLIONS)
      • FIGURE 4: MARKET SHARE OF MAJOR IVD MARKET COMPANIES, 2014 (%)

CHAPTER 5 - GLOBAL IMMUNOCHEMISTRY MARKET

  • APPLICATIONS
    • BLOOD GAS, ELECTROLYTES AND METABOLITES (BGEM)
    • ENDOCRINE
    • INFECTIOUS DISEASES
    • CANCER
    • URINALYSIS
    • DIABETES
    • CARDIOLOGY
    • BLOOD SCREENING
    • OTHERS
      • TABLE 5: GLOBAL IMMUNOCHEMISTRY MARKET BY APPLICATION THROUGH 2020 ($ MILLIONS)
      • FIGURE 5: GLOBAL IMMUNOCHEMISTRY MARKET SHARE BY APPLICATION, 2014 (%)
      • TABLE 6: GLOBAL IMMUNOCHEMISTRY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 6: GLOBAL IMMUNOCHEMISTRY MARKET BY REGION, 2013-2020 ($ MILLIONS)

CHAPTER 6 - GLOBAL POC TESTING MARKET

  • APPLICATIONS
    • GLUCOSE TESTING
    • BGEM
    • CARDIAC MARKER TESTING
    • INFECTIOUS DISEASE TESTING
    • PREGNANCY AND FERTILITY TESTING
    • DRUG AND ALCOHOL ABUSE TESTING
    • HEMATOLOGY AND HEMOSTASIS TESTING
    • CHOLESTEROL TESTING
    • URINE CHEMISTRY TESTING
    • TUMOR MARKER TESTING
    • OTHER POC TESTING
      • TABLE 7: GLOBAL POC TESTING MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 7: GLOBAL POC TESTING MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
      • FIGURE 8: GLOBAL POC TESTING MARKET SHARE BY APPLICATION, 2014 (%)
      • TABLE 8: GLOBAL POC TESTING MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 9: GLOBAL POC TESTING MARKET BY REGION, 2013-2020 ($ MILLIONS)

CHAPTER 7 - GLOBAL HEMATOLOGY MARKET

  • APPLICATIONS
    • ROUTINE HEMATOLOGY TESTS
    • HEMOSTASIS
      • TABLE 9: GLOBAL HEMATOLOGY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 10: GLOBAL HEMATOLOGY MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
      • FIGURE 11: GLOBAL HEMATOLOGY MARKET SHARE BY APPLICATION, 2014 (%)
      • FIGURE 12: GLOBAL HEMATOLOGY MARKET SHARE BY TECHNIQUE, 2014 (%)
      • FIGURE 13: GLOBAL HEMATOLOGY MARKET SHARE BY TECHNIQUE, 2014 (%)
      • TABLE 10: GLOBAL HEMATOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 14: GLOBAL HEMATOLOGY MARKET BY REGION, 2013-2020 ($ MILLIONS)

CHAPTER 8 - GLOBAL MOLECULAR DIAGNOSTICS MARKET

  • APPLICATIONS
    • INFECTIOUS DISEASES
    • BLOOD SCREENING
    • ONCOLOGY
    • GENETIC TESTING
    • OTHERS (COMPANION DIAGNOSTICS, PRENATAL GENETIC TESTS AND RARE DISEASES)
      • TABLE 11: GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION THROUGH 2020 ($MILLIONS)
      • FIGURE 15: GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
      • FIGURE 16: GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATION, 2014 (%)
      • FIGURE 17: GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SHARE BY DISEASE, 2014 (%)
      • FIGURE 18: COMPANION DIAGNOSTIC TESTS BY YEAR APPROVED, 1994-2014 (NO. OF TESTS)
      • TABLE 12: COMPANION DIAGNOSTIC TESTS MANUFACTURERS BY NUMBER OF TESTS, 2013
      • TABLE 13: FDA-APPROVED NUCLEIC ACID BASED TESTS FOR GENETIC CONDITIONS
      • TABLE 14: FDA-APPROVED COMPANION DIAGNOSTIC TESTS
      • TABLE 15: GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 19: GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2013-2020 ($ MILLIONS)

CHAPTER 9 - GLOBAL CLINICAL MICROBIOLOGY MARKET

  • APPLICATIONS
    • BLOOD CULTURE
    • GENERAL CULTURE (URINE/SALIVA/STOOL/SPUTUM/CSF AND OTHER BODY FLUIDS)
    • IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY TESTING
      • TABLE 16: GLOBAL CLINICAL MICROBIOLOGY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 20: GLOBAL CLINICAL MICROBIOLOGY MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
      • FIGURE 21: GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE BY APPLICATION, 2014 (%)
      • TABLE 17: GLOBAL CLINICAL MICROBIOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 22: GLOBAL CLINICAL MICROBIOLOGY MARKET BY REGION, 2013-2020 ($ MILLIONS)

CHAPTER 10 - GLOBAL TISSUE DIAGNOSTICS MARKET

  • APPLICATIONS
    • CANCER DIAGNOSIS
    • TISSUE TYPING
    • PATHOGEN DETECTION
      • TABLE 18: GLOBAL TISSUE DIAGNOSTICS MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 23: GLOBAL TISSUE DIAGNOSTICS MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
      • FIGURE 24: GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY APPLICATION, 2014 (%)
      • TABLE 19: GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 25: GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, 2013-2020 ($ MILLIONS)

CHAPTER 11 - GLOBAL IVD MARKET BY END USERS

  • INTRODUCTION
  • TRENDS
    • FIGURE 26: GLOBAL IVD MARKET SHARE BY END USER, 2014 (%)

CHAPTER 12 - GLOBAL IVD MARKET PRODUCTS

  • INTRODUCTION
    • TRENDS
      • FIGURE 27: GLOBAL IVD MARKET SHARE BY PRODUCT TYPE, 2014 (%)

CHAPTER 13 - REGIONAL ANALYSIS

  • INTRODUCTION
  • NORTH AMERICA
  • EUROPE
  • ASIA
  • LAAM
  • INTERNATIONAL HEALTH EXPENDITURE AND TRENDS
    • FIGURE 28: TOTAL HEALTH EXPENDITURE AS A PERCENTAGE OF GDP FOR THE TOP INDUSTRIALIZED ECONOMIES, 2010 (%)
    • TABLE 20: GLOBAL IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 29: GLOBAL IVD MARKET SHARE BY REGION, 2014 (%)
  • NORTH AMERICA
    • TABLE 21: NORTH AMERICA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 30: NORTH AMERICA IVD MARKET SHARE BY COUNTRY, 2014 (%)
    • TABLE 22: NORTH AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
  • U.S.
    • TABLE 23: U.S. IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
  • CANADA
    • TABLE 24: CANADA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
  • EUROPE
    • WESTERN EUROPE (WE)
      • CENTRAL AND EASTERN EUROPE (CEE)
        • TABLE 25: EUROPE IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
        • FIGURE 31: EUROPE IVD MARKET SHARE BY COUNTRY, 2014 (%)
        • FIGURE 32: WE IVD MARKET SHARE BY COUNTRY, 2014 (%)
        • FIGURE 33: CEE IVD MARKET SHARE BY COUNTRY, 2014 (%)
        • TABLE 26: EUROPE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • WESTERN EUROPE
      • GERMANY
        • TABLE 27: GERMANY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • FRANCE
        • TABLE 28: FRANCE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • ITALY
        • TABLE 29: ITALY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • SPAIN
        • TABLE 30: SPAIN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • U.K.
        • TABLE 31: U.K. IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • OTHERS
        • TABLE 32: OTHERS IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • CENTRAL AND EASTERN EUROPE
      • TURKEY
        • TABLE 33: TURKEY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • RUSSIA
        • TABLE 34: RUSSIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • POLAND
        • TABLE 35: POLAND IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • GREECE
        • TABLE 36: GREECE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • CZECH REPUBLIC
        • TABLE 37: CZECH REPUBLIC IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
      • OTHERS
        • TABLE 38: OTHERS IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
  • ASIA
    • TABLE 39: ASIA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 34: ASIA IVD MARKET SHARE BY COUNTRY, 2013-2020 (%)
    • TABLE 40: ASIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • JAPAN
      • TABLE 41: JAPAN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • CHINA
      • TABLE 42: CHINA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • AUSTRALIA
      • TABLE 43: AUSTRALIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • INDIA
      • TABLE 44: INDIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • SOUTH KOREA
      • TABLE 45: SOUTH KOREA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TAIWAN
      • TABLE 46: TAIWAN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • REST OF ASIA
      • TABLE 47: REST OF ASIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
  • LATIN AMERICA, AFRICA AND MIDDLE EAST (LAAM)
    • TABLE 48: LAAM IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: LAAM IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
  • LATIN AMERICA
    • TABLE 50: LATIN AMERICA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 35: LATIN AMERICA IVD MARKET SHARE BY COUNTRY, 2014 (%)
    • TABLE 51: LATIN AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • BRAZIL
      • TABLE 52: BRAZIL IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • MEXICO
      • TABLE 53: MEXICO IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • REST OF LATIN AMERICA
      • TABLE 54: REST OF LATIN AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
  • MIDDLE EAST AND AFRICA (MEA)
    • TABLE 55: MIDDLE EAST AND AFRICA IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 36: MIDDLE EAST AND AFRICA IVD MARKET SHARE BY REGION, 2014 (%)
    • TABLE 56: MIDDLE EAST AND AFRICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)

CHAPTER 14 - EMERGING GLOBAL TECHNOLOGY TRENDS AND DEVELOPMENTS

  • TRENDS
  • INDUSTRY DEVELOPMENTS
    • RAPID FINGER PRICK EBOLA TEST
    • ROCHE DIAGNOSTICS' ELECSYS HTLV-I/II
    • HIV COMBO ASSAY
    • BLOOD-BASED GENETIC ASSAY
    • PORTABLE MOLECULAR DIAGNOSTICS SYSTEM GENEXPERT OMNI
    • NEW INSTRUMENTS AND ASSAYS AT AACC 2015
    • INOVA DIAGNOSTICS' QUANTA FLASH ASSAYS
    • LEADCARE PLUS CLINICAL LEAD ANALYZER
    • DIAGNOSTIC TEST TO DIFFERENTIATE BETWEEN TYPES OF HIV INFECTIONS
    • IMMUNOCHEMICAL POC TESTING IN FIVE MINUTES
    • ASSAYS FOR DETECTING FOODBORNE PATHOGENS
    • TEST TO DETECT PATHOGENIC C. DIFFICILE
    • MOLECULAR DIAGNOSTIC TESTS FOR ONCOLOGY
    • RAPID DIAGNOSTIC TEST FOR MALARIA
    • EMERGING APPROACHES TO DIAGNOSIS OF MALARIA
      • TABLE 57: EMERGING APPROACHES TO MALARIA DIAGNOSIS
    • MALARIA IVD TECHNOLOGIES IN DEVELOPMENT
      • TABLE 58: MALARIA DIAGNOSTIC TECHNOLOGIES UNDER DEVELOPMENT
      • TABLE 59: IVD PRODUCT APPROVALS, 2014-2015
  • ACADEMIC RESEARCH AND DEVELOPMENT
    • RAPID TECHNIQUE TO DETECT DISEASE-CAUSING DNA
    • SALIVA TEST TO PREDICT ALZHEIMER'S DISEASE
    • MOBILE DNA TEST FOR CHLAMYDIA
    • BLOOD TEST FOR VIRAL INFECTIONS
    • RAPID IVD FOR DENGUE

CHAPTER 15 - TECHNOLOGY DEVELOPMENT OPPORTUNITIES IN IVD INDUSTRY

  • OPPORTUNITY AREAS
    • IVD FOR NEGLECTED INFECTIOUS DISEASES
    • PORTABLE DEVICES COMPATIBLE WITH SIMPLE DETECTION PLATFORMS
    • CHEMISTRY-BASED PORTABLE ANALYZERS
    • IMPROVED SAMPLE PRESERVATION TECHNOLOGIES
    • NEW DETECTION TECHNOLOGIES
    • ALTERNATIVE TECHNOLOGIES TO PCR
    • KEY BIOMARKERS FOR DISEASES OF THE DEVELOPING WORLD
      • FIGURE 37: BIOMARKER RELATED PUBLICATIONS, 2009-2014 (NO. OF PUBLICATIONS)
      • FIGURE 38: BIOMARKER-BASED TESTS CLEARED BY 510(K), 2009-2014 (NO. OF BIOMARKER-BASED TESTS)
      • TABLE 60: BIOMARKER-BASED TESTS RELEASED PER COMPANY, 2013 (NO. OF TESTS)
      • FIGURE 39: BIOMARKERS IN FDA-CLEARED TESTS, 2010-2014 (NO. OF TESTS CLEARED)
    • MICROFLUIDIC PLATFORM BASED POC TESTS FOR REMOTE SETTINGS
    • COMBINING MULTIPLE DETECTION TECHNOLOGIES INTO A SINGLE INSTRUMENT

CHAPTER 16 - FUNDING ANALYSIS AND INDUSTRY ACTIVITY

  • PUBLIC FUNDING
    • EUROPE
    • U.S.
      • FIGURE 40: NCI'S FUNDING SHARE FOR IVDS AND VARIOUS OTHER DISCIPLINES, 2014 (%)
    • SWISS-BASED SERI FUNDS EBOLA DIAGNOSTICS WORK BY FIND
    • EUROPEAN UNION AWARD FOR FABPULOUS BV FOR CARDIAC IVD
  • PRIVATE FUNDING
    • CANADIAN START-UP XAGENIC RECEIVES SERIES B VC FUNDING
    • BLOOD-BASED IVD FOR CANCER
    • OPTICS-BASED IVD
    • IVD FOR LIVER DISEASES
    • DNA-BASED IVD FOR PRENATAL AND CANCER TESTING
    • IVD FOR ORAL CANCER
    • IVD FOR BLADDER CANCER
    • TESTS FOR INFECTIOUS DISEASES AND CANCERS
    • TAIWAN-BASED MOLECULAR DIAGNOSTICS FIRM RECEIVES PRIVATE FUNDING
  • MERGERS AND ACQUISITIONS
    • FIGURE 41: IVD MERGERS AND ACQUISITIONS, 2012-2015 (NO. OF DEALS)
    • FIGURE 42: SHARE OF MERGERS AND ACQUISITIONS BY CATEGORY, 2012-2015 (%)
    • TABLE 61: MERGERS AND ACQUISITIONS, 2012-JUNE 2015

CHAPTER 17 - PATENT LANDSCAPE

  • FIGURE 43: PATENTS BY PUBLICATION DATE, 2012-JUNE 2015 (NUMBERS)
  • FIGURE 44 :PATENTS BY SUBSEGMENT AND PUBLICATION DATE, 2012--JUNE 2015 (NUMBERS)
  • IMMUNOASSAYS
    • FIGURE 45: IMMUNOASSAYS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
  • CLINICAL CHEMISTRY
    • FIGURE 46: CLINICAL CHEMISTRY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
  • POC TESTING
    • FIGURE 47: POCT PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
  • MOLECULAR DIAGNOSTICS
    • FIGURE 48: MOLECULAR DIAGNOSTICS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
  • MICROBIOLOGY
    • FIGURE 49: MICROBIOLOGY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015* (NUMBERS)
  • HEMATOLOGY
    • FIGURE 50: HEMATOLOGY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
  • TISSUE DIAGNOSTICS
    • FIGURE 51: TISSUE DIAGNOSTICS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)

CHAPTER 18 - COMPANY PROFILES

  • ABBOTT DIAGNOSTICS INC.
    • GEOGRAPHIC REACH
    • GLOBAL REACH
    • SALES AND MARKETING
    • STRATEGY
  • ALERE SAN DIEGO INC.
    • GEOGRAPHIC REACH
    • SALES AND MARKETING
    • STRATEGY
    • BAYER DIABETES CARE (NOW PART OF PANASONIC HEALTHCARE)
  • BECKMAN COULTER (PART OF DANAHER)
    • GEOGRAPHIC REACH
    • OPERATIONS
    • SALES AND MARKETING
    • STRATEGY
  • BECTON DICKINSON
    • STRATEGY
    • BIOMERIEUX
    • GLOBAL REACH
    • SALES AND MARKETING
    • STRATEGY
  • BIORAD
    • SALES AND MARKETING
  • ELITECH GROUP
  • HOLOGIC INC.
    • SALES AND MARKETING
  • KEM-EN-TEC DIAGNOSTICS A/S
  • ORTHO CLINICAL DIAGNOSTICS
  • ROCHE DIAGNOSTICS CORP.
    • GEOGRAPHIC REACH
    • SALES AND MARKETING
    • FINANCIAL PERFORMANCE
    • STRATEGY
  • SIEMENS HEALTHCARE DIAGNOSTICS INC.
    • GEOGRAPHIC REACH
    • SALES AND MARKETING
    • STRATEGY
  • SYSMEX
  • THERMO FISHER SCIENTIFIC INC.
    • STRATEGY
  • TRANSASIA BIO-MEDICALS
  • WERFEN GROUP

CHAPTER 19 - APPENDIX

  • LIST OF IVD MARKET PARTICIPANTS
  • LIST OF ABBREVIATIONS

LIST OF TABLES

  • SUMMARY TABLE GLOBAL IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: TYPES OF DIAGNOSTIC TESTS AND HOW THEY ARE REGULATED
    • TABLE 2: CHANGES IN IVD REGULATIONS IN ASIA
    • TABLE 3: GLOBAL IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 4: MAJOR IVD MARKET COMPANIES, 2014 ($ MILLIONS)
    • TABLE 5: GLOBAL IMMUNOCHEMISTRY MARKET BY APPLICATION THROUGH 2020 ($ MILLIONS)
    • TABLE 6: GLOBAL IMMUNOCHEMISTRY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 7: GLOBAL POC TESTING MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 8: GLOBAL POC TESTING MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 9: GLOBAL HEMATOLOGY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 10: GLOBAL HEMATOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION THROUGH 2020 ($MILLIONS)
    • TABLE 12: COMPANION DIAGNOSTIC TESTS MANUFACTURERS BY NUMBER OF TESTS, 2013
    • TABLE 13: FDA-APPROVED NUCLEIC ACID BASED TESTS FOR GENETIC CONDITIONS
    • TABLE 14: FDA-APPROVED COMPANION DIAGNOSTIC TESTS
    • TABLE 15: GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: GLOBAL CLINICAL MICROBIOLOGY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: GLOBAL CLINICAL MICROBIOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 18: GLOBAL TISSUE DIAGNOSTICS MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 19: GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: GLOBAL IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 21: NORTH AMERICA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: NORTH AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: U.S. IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 24: CANADA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: EUROPE IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 26: EUROPE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: GERMANY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 28: FRANCE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: ITALY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 30: SPAIN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 31: U.K. IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 32: OTHERS IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: TURKEY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 34: RUSSIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 35: POLAND IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 36: GREECE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: CZECH REPUBLIC IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: OTHERS IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: ASIA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: ASIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: JAPAN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: CHINA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 43: AUSTRALIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 44: INDIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 45: SOUTH KOREA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 46: TAIWAN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 47: REST OF ASIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 48: LAAM IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: LAAM IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 50: LATIN AMERICA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 51: LATIN AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 52: BRAZIL IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 53: MEXICO IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 54: REST OF LATIN AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 55: MIDDLE EAST AND AFRICA IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 56: MIDDLE EAST AND AFRICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
    • TABLE 57: EMERGING APPROACHES TO MALARIA DIAGNOSIS
    • TABLE 58: MALARIA DIAGNOSTIC TECHNOLOGIES UNDER DEVELOPMENT
    • TABLE 59: IVD PRODUCT APPROVALS, 2014-2015
    • TABLE 60: BIOMARKER-BASED TESTS RELEASED PER COMPANY, 2013 (NO. OF TESTS)
    • TABLE 61: MERGERS AND ACQUISITIONS, 2012-JUNE 2015

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL IVD MARKET BY REGION, 2013-2020 ($ MILLIONS)
    • FIGURE 1: MARKET SEGMENTATION
    • FIGURE 2: GLOBAL IVD MARKET BY SEGMENT, 2013-2020 ($ MILLIONS)
    • FIGURE 3: GLOBAL IVD MARKET SHARE BY SEGMENT, 2014 (%)
    • FIGURE 4: MARKET SHARE OF MAJOR IVD MARKET COMPANIES, 2014 (%)
    • FIGURE 5: GLOBAL IMMUNOCHEMISTRY MARKET SHARE BY APPLICATION, 2014 (%)
    • FIGURE 6: GLOBAL IMMUNOCHEMISTRY MARKET BY REGION, 2013-2020 ($ MILLIONS)
    • FIGURE 7: GLOBAL POC TESTING MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
    • FIGURE 8: GLOBAL POC TESTING MARKET SHARE BY APPLICATION, 2014 (%)
    • FIGURE 9: GLOBAL POC TESTING MARKET BY REGION, 2013-2020 ($ MILLIONS)
    • FIGURE 10: GLOBAL HEMATOLOGY MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
    • FIGURE 11: GLOBAL HEMATOLOGY MARKET SHARE BY APPLICATION, 2014 (%)
    • FIGURE 12: GLOBAL HEMATOLOGY MARKET SHARE BY TECHNIQUE, 2014 (%)
    • FIGURE 13: GLOBAL HEMATOLOGY MARKET SHARE BY TECHNIQUE, 2014 (%)
    • FIGURE 14: GLOBAL HEMATOLOGY MARKET BY REGION, 2013-2020 ($ MILLIONS)
    • FIGURE 15: GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
    • FIGURE 16: GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATION, 2014 (%)
    • FIGURE 17: GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SHARE BY DISEASE, 2014 (%)
    • FIGURE 18: COMPANION DIAGNOSTIC TESTS BY YEAR APPROVED, 1994-2014 (NO. OF TESTS)
    • FIGURE 19: GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2013-2020 ($ MILLIONS)
    • FIGURE 20: GLOBAL CLINICAL MICROBIOLOGY MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
    • FIGURE 21: GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE BY APPLICATION, 2014 (%)
    • FIGURE 22: GLOBAL CLINICAL MICROBIOLOGY MARKET BY REGION, 2013-2020 ($ MILLIONS)
    • FIGURE 23: GLOBAL TISSUE DIAGNOSTICS MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
    • FIGURE 24: GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY APPLICATION, 2014 (%)
    • FIGURE 25: GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, 2013-2020 ($ MILLIONS)
    • FIGURE 26: GLOBAL IVD MARKET SHARE BY END USER, 2014 (%)
    • FIGURE 27: GLOBAL IVD MARKET SHARE BY PRODUCT TYPE, 2014 (%)
    • FIGURE 28: TOTAL HEALTH EXPENDITURE AS A PERCENTAGE OF GDP FOR THE TOP INDUSTRIALIZED ECONOMIES, 2010 (%)
    • FIGURE 29: GLOBAL IVD MARKET SHARE BY REGION, 2014 (%)
    • FIGURE 30: NORTH AMERICA IVD MARKET SHARE BY COUNTRY, 2014 (%)
    • FIGURE 31: EUROPE IVD MARKET SHARE BY COUNTRY, 2014 (%)
    • FIGURE 32: WE IVD MARKET SHARE BY COUNTRY, 2014 (%)
    • FIGURE 33: CEE IVD MARKET SHARE BY COUNTRY, 2014 (%)
    • FIGURE 34: ASIA IVD MARKET SHARE BY COUNTRY, 2013-2020 (%)
    • FIGURE 35: LATIN AMERICA IVD MARKET SHARE BY COUNTRY, 2014 (%)
    • FIGURE 36: MIDDLE EAST AND AFRICA IVD MARKET SHARE BY REGION, 2014 (%)
    • FIGURE 37: BIOMARKER RELATED PUBLICATIONS, 2009-2014 (NO. OF PUBLICATIONS)
    • FIGURE 38: BIOMARKER-BASED TESTS CLEARED BY 510(K), 2009-2014 (NO. OF BIOMARKER-BASED TESTS)
    • FIGURE 39: BIOMARKERS IN FDA-CLEARED TESTS, 2010-2014 (NO. OF TESTS CLEARED)
    • FIGURE 40: NCI'S FUNDING SHARE FOR IVDS AND VARIOUS OTHER DISCIPLINES, 2014 (%)
    • FIGURE 41: IVD MERGERS AND ACQUISITIONS, 2012-2015 (NO. OF DEALS)
    • FIGURE 42: SHARE OF MERGERS AND ACQUISITIONS BY CATEGORY, 2012-2015 (%)
    • FIGURE 43: PATENTS BY PUBLICATION DATE, 2012-JUNE 2015 (NUMBERS)
    • FIGURE 44: PATENTS BY SUBSEGMENT AND PUBLICATION DATE, 2012--JUNE 2015 (NUMBERS)
    • FIGURE 45: IMMUNOASSAYS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
    • FIGURE 46: CLINICAL CHEMISTRY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
    • FIGURE 47: POCT PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
    • FIGURE 48: MOLECULAR DIAGNOSTICS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
    • FIGURE 49: MICROBIOLOGY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015* (NUMBERS)
    • FIGURE 50: HEMATOLOGY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
    • FIGURE 51: TISSUE DIAGNOSTICS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
Back to Top